ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,749.00
0.35%
S&P ASX All Technology
3,067.50
0.14%
Brent Oil
82.585
0.00%
US Dollar vs AUD
1.50761
0.00%
Bitcoin
60,908.98
0.18%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Alcon Inc (ALC)

  7. Alcon Inc (ALC) News

ALC

Alcon (ALC)

Alcon Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:ALC
DateTimeSourceHeadlineSymbolCompany
09/05/202406:30Business WireAlcon Announces Results of 2024 Annual General MeetingNYSE:ALCAlcon Inc
01/05/202423:45Business WireAlgoma Central Corporation Reports Financial Results for the 2024 First QuarterNYSE:ALCAlcon Inc
08/04/202407:59Business WireAlcon Publishes Agenda for 2024 Annual General MeetingNYSE:ALCAlcon Inc
12/03/202419:30Business WireAlcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in IndiaNYSE:ALCAlcon Inc
07/03/202401:55Business WireVivity, the World’s Leading EDOF IOL, Reaches One Million MilestoneNYSE:ALCAlcon Inc
07/03/202401:55Business WireVivity, la LIO à profondeur focale accrue première au monde, atteint un million d’implantsNYSE:ALCAlcon Inc
07/03/202400:00Business WireVivity, the World’s Leading EDOF IOL, Reaches One Million MilestoneNYSE:ALCAlcon Inc
02/03/202410:44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ALCAlcon Inc
01/03/202409:56Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ALCAlcon Inc
01/03/202405:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ALCAlcon Inc
28/02/202408:30Business WireAlcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023NYSE:ALCAlcon Inc
26/02/202423:00Business WireAlgoma Central Corporation Reports Financial Results for Fiscal 2023NYSE:ALCAlcon Inc
13/02/202408:22Business WireAlgoma Central Corporation to Issue Fiscal 2023 Financial Results on February 26, 2024NYSE:ALCAlcon Inc
02/02/202405:04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:ALCAlcon Inc
02/02/202401:02Business WireAlcon Canada lance les lentilles cornéennes TOTAL30 Multifocal pour les patients porteurs de lentilles réutilisables atteints de presbytieNYSE:ALCAlcon Inc
19/01/202400:54Business WireAlgoma Central Corporation continues to grow product tanker business with the acquisition of two additional vesselsNYSE:ALCAlcon Inc
10/01/202420:12Dow Jones NewsAlcon Shares Rise After Dry-Eye Care Drug Shows Promising ResultsNYSE:ALCAlcon Inc
10/01/202409:20Dow Jones NewsAlcon Reports Results for Dry-Eye-Treatment TrialsNYSE:ALCAlcon Inc
10/01/202408:30Business WireAlcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry EyeNYSE:ALCAlcon Inc
10/01/202408:30Business WireAlcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry EyeNYSE:ALCAlcon Inc
06/01/202400:00GlobeNewswire Inc.Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial ArrangementsNYSE:ALCAlcon Inc
28/12/202301:01Business WireAlcon to Present at 2024 Annual J.P. Morgan Healthcare ConferenceNYSE:ALCAlcon Inc
16/11/202303:08Dow Jones NewsAlcon Down Over 5%, On Track for Largest Percent Decrease Since May 2022 -- Data TalkNYSE:ALCAlcon Inc
15/11/202322:11Dow Jones NewsAlcon's Swiss Shares Drop After Guidance Narrowed to Lower End of RangeNYSE:ALCAlcon Inc
15/11/202308:30Business WireAlcon Reports Third Quarter 2023 ResultsNYSE:ALCAlcon Inc
09/11/202301:03Business WireAlcon Canada lance Clareon Vivity, sa plus récente avancée en matière de LIO pour la correction de la presbytieNYSE:ALCAlcon Inc
04/11/202306:00Business WireAlgoma Central Corporation Reports Financial Performance for the 2023 Third QuarterNYSE:ALCAlcon Inc
31/10/202300:01Business WireAlcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023NYSE:ALCAlcon Inc
27/10/202322:00Business WireAlgoma Central Corporation to Issue Third Quarter 2023 Financial Results on November 3, 2023NYSE:ALCAlcon Inc
10/10/202323:01Business WireAlcon Launches TOTAL30 Multifocal Contact Lenses for Patients with PresbyopiaNYSE:ALCAlcon Inc
 Showing the most relevant articles for your search:NYSE:ALC

Your Recent History

BIT
F15429
Vontobel Financial Produ...
USOTC
QEXXF
Quattro Exploration and ... (CE)
USOTC
APHLF
Alpha Lithium (PK)
AMEX
XONE
Bondbloxx Bloomberg One ...
NASDAQ
CLPS
CLPS Incorporation
COIN
ASRGBP
AS Roma
NASDAQ
MSFT
Microsoft
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved